Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The target "General transcription factor IIi pseudogene 14" (abbreviated as GTF2IP14) appears to be a pseudogene related to the functional gene GTF2I, which encodes a transcription factor involved in gene regulation, cell growth, and myelination[1][5]. However, GTF2IP14 itself is a pseudogene, meaning it does not encode a functional protein and is not considered a therapeutic target or functional receptor, enzyme, or transcription factor. There is no evidence supporting GTF2IP14 as having biological functions, disease involvement, interacting drugs, or clinical relevance. Its inclusion as a target is likely incorrect or based on a misinterpretation of gene nomenclature conventions, as only the parental gene (GTF2I) encodes a functional protein[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on General transcription factor IIi pseudogene 14 (GTF2IP14).